WNT5A and breast cancer: The 8-year RFS rate of Wnt5a-positive breast cancer patients was lower than that of Wnt5a-negative patients [(91.9% (95% CI = 85.1–98.7) vs 98.6%, (95% CI = 96.0–100.0), P = 0.047] (Fig. 1).